Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,954.00
(
-0.25%
)
Dow Jones
46,946.41
(
0.00%
)
Brent Oil
100.10
(
1.83%
)
Bitcoin
74,097.45
(
-1.00%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 110381

Wednesday, 12/08/2010 12:03:58 AM

Wednesday, December 08, 2010 12:03:58 AM

Post# of 257251
On a probability-weighted basis, genericization of Angiomax is (IMO) a bigger impediment to M118’s commercial success than are the new oral anticoagulants. It sounds like you think so too.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now